183 related articles for article (PubMed ID: 2478845)
21. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T
Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632
[No Abstract] [Full Text] [Related]
22. Alpha-fetoprotein in hepatic pathology and hepatocarcinoma.
Piantino P; Arrigoni A; Brunetto MR; Gindro T
J Nucl Med Allied Sci; 1989; 33(3 Suppl):34-8. PubMed ID: 2480419
[TBL] [Abstract][Full Text] [Related]
23. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
24. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
[TBL] [Abstract][Full Text] [Related]
25. Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
Zaninotto M; Ujka F; Lachin M; Bernardi D; Marafi C; Farinati F; Plebani M
Anticancer Res; 1996; 16(1):305-9. PubMed ID: 8615626
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
27. Serum alpha-fetoprotein in chronic liver disease.
Weisz G; Udvardy M; Dalmi L; Kulcsár A
Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
30. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Yin ZF; Tu ZX; Cui ZF; Wu MC
Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
[TBL] [Abstract][Full Text] [Related]
32. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
33. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
34. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
35. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
[TBL] [Abstract][Full Text] [Related]
36. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
37. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Lamerz R; Runge M; Stieber P; Meissner E
Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
[TBL] [Abstract][Full Text] [Related]
38. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
[TBL] [Abstract][Full Text] [Related]
39. [Serum concentrations of tissue polypeptide antigen and alpha 1-fetoprotein in patients with primary liver cancer, liver metastasis and liver cirrhosis].
Polterauer P; Legenstein E; Müller M
Wien Klin Wochenschr; 1985 Apr; 97(9):417-20. PubMed ID: 2408389
[TBL] [Abstract][Full Text] [Related]
40. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
